T-HCA
Trans-4-Hydroxycrotonic acid (T-HCA) is a pharmacologically significant compound that has garnered attention in the field of scientific research due to its structural and functional relationship with Gamma-Hydroxybutyric Acid (GHB). Although closely related to GHB, T-HCA showcases unique binding characteristics and does not display the typical sedative effects associated with GHB. Additionally, evidence suggests that T-HCA might be endogenously produced in the mammalian central nervous system, raising the hypothesis that it could function as a natural ligand for the GHB receptor.
Chemical Properties and Relationship to GHB
Structural Kinship: T-HCA is structurally akin to GHB, a compound known for its sedative and euphoric effects. Binding Affinity: Despite its structural resemblance, T-HCA exhibits a 4-fold higher binding affinity to the GHB receptor than GHB itself[1].
Pharmacological Actions
- Non-Sedative: Contrary to GHB, T-HCA does not activate the primary sedative target, the GABAB receptor. As such, it doesn't elicit the sedative responses commonly seen with GHB.
- Convulsive Effects: T-HCA has been documented to induce convulsions, a phenomenon believed to be a consequence of heightened glutamate release.
- Potential Endogenous Role: Given the notion that T-HCA might be naturally synthesized in the mammalian central nervous system, it's speculated to serve as an endogenous ligand for the GHB receptor.
Therapeutic Implications and Research Applications
- Neurological Insights: The ability of T-HCA to induce convulsions offers a potential model for studying seizure mechanisms and exploring therapeutic interventions.
- Endogenous Function: Establishing T-HCA as a naturally occurring ligand in the central nervous system might pave the way for understanding novel neuromodulatory processes.
- GHB Receptor Function: T-HCA's differential binding and functional characteristics, in comparison to GHB, can elucidate the broader roles and functions of the GHB receptor in neural systems.
Conclusion
Trans-4-Hydroxycrotonic acid provides a compelling avenue for investigating the complex interactions within the GABAergic system and its associated receptors. Its unique pharmacological profile and potential endogenous role in the mammalian central nervous system position T-HCA as a molecule of great interest in neuropharmacological research.
References
- Benavides, J., et al. (1982). Specific GHB-binding sites in rat and human brain. Biochemical Pharmacology, 31(13), 2161-2164.
See also
| GHB receptor modulators | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- ↑ Benavides, J., et al. (1982). Specific GHB-binding sites in rat and human brain. Biochemical Pharmacology, 31(13), 2161-2164.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD